Changes in Cerebral Oxygenation and Cognitive Functions

June 22, 2021 updated by: Bengü Gülhan Aydin, Zonguldak Bulent Ecevit University

Changes in Cerebral Oxygenation and Cognitive Functions During Controlled Hypotension

The present study aimed to assess the influence of nitroglycerin and esmolol-induced hypotension on cerebral oxygen saturation by using near-infrared spectroscopy and postoperative cognitive function in patients undergoing nasal surgery.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

40

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Kozlu
      • Zonguldak, Kozlu, Turkey, 67600
        • Zonguldak Bülent Ecevit University medicine faculty

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

- required controlled hypotension scheduled for nasal surgeries

Description

Inclusion Criteria:

  • written informed consent
  • patients with ASA physical status of I-II
  • aged 18-65 years

Exclusion Criteria:

  • Age under 18 or above 65
  • ASA > II
  • coagulation disorders
  • history of cardiovascular and cerebrovascular disease
  • poor Blood Pressure control
  • anemia, pregnancy, addiction to opioids
  • body mass index (BMI) > 35
  • intraoperative systolic BP < 65 mmHg
  • surgical duration less than 30 minutes or more than 160 minutes
  • need for an intraoperative sympathomimetic drug and the use of other hypotensive drugs
  • preoperative Mini-Mental State Examination (MMSE) score of 23 or less.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
esmolol (Group E)
nitroglycerin (Group N)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
effects of controlled hypotension on cerebral oxygen saturation
Time Frame: until end of the surgical procedure.
influence of nitroglycerin and esmolol-induced hypotension on cerebral oxygen saturation by measuring regional cerebral oxygen saturation using Near-Infrared Spectroscopy
until end of the surgical procedure.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
effects of controlled hypotension on cognitive function
Time Frame: 24 hour before surgery and 24 hour after surgery
influence of nitroglycerin and esmolol-induced hypotension on postoperative cognitive function using mini mental test score
24 hour before surgery and 24 hour after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2014

Primary Completion (Actual)

January 1, 2016

Study Completion (Actual)

August 1, 2016

Study Registration Dates

First Submitted

June 12, 2021

First Submitted That Met QC Criteria

June 22, 2021

First Posted (Actual)

July 2, 2021

Study Record Updates

Last Update Posted (Actual)

July 2, 2021

Last Update Submitted That Met QC Criteria

June 22, 2021

Last Verified

June 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cognitive Dysfunction

Clinical Trials on Nitroglycerin

3
Subscribe